Bulletin 2010/31 - European Patent Office
Bulletin 2010/31 - European Patent Office
Bulletin 2010/31 - European Patent Office
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(C07F) I.1(2)<br />
• PROCÉDÉ DE PRODUCTION D'UN SEL DE<br />
TERRE RARE D'ESTER DE DIALKYL-<br />
PHOSPHATE OU D'UN SEL DE TERRE<br />
RARE D'ESTER DE DIOLÉYLPHOSPHATE<br />
(71) Bridgestone Corporation, 10-1, Kyobashi 1chome<br />
Chuo-ku, Tokyo 104-8340, JP<br />
(72) OZAWA, Yoichi, Kodaira-shi Tokyo 187-<br />
85<strong>31</strong>, JP<br />
SUZUKI, Hideaki, Kawasaki-shi Kanagawa<br />
213-0032, JP<br />
(74) Whalley, Kevin, et al, Marks & Clerk LLP, 90<br />
Long Acre London WC2E 9RA, GB<br />
C07F 9/11 → (51) C07F 9/09<br />
C07F 17/02 → (51) C07C 41/09<br />
(51) C07G 1/00 (11) 2 213 678 A1<br />
C07H 3/02<br />
(25) Ja (26) En<br />
(21) 08840157.5 (22) 15.10.2008<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MT NL<br />
NO PL PT RO SE SI SK TR<br />
AL BA MK RS<br />
(86) JP 2008/002912 15.10.2008<br />
(87) WO 2009/050882 2009/17 23.04.2009<br />
(30) 17.10.2007 JP 2007269704<br />
(54) • HERSTELLUNGSVERFAHREN FÜR<br />
GELÖSTES LIGNIN, SACCHARIDAUS-<br />
GANGSSTOFF UND MONOSACCHARI-<br />
DAUSGANGSSTOFF SOWIE GELÖSTES<br />
LIGNIN<br />
• PRODUCTION METHODS FOR SOLUBI-<br />
LIZED LIGNIN, SACCHARIDE RAW MATE-<br />
RIAL AND MONOSACCHARIDE RAW<br />
MATERIAL, AND SOLUBILIZED LIGNIN<br />
• PROCÉDÉS DE FABRICATION DE LIGNINE<br />
SOLUBILISÉE, DE MATIÈRE PREMIÈRE<br />
SACCHARIDIQUE ET DE MATIÈRE PRE-<br />
MIÈRE MONOSACCHARIDIQUE ET<br />
LIGNINE SOLUBILISÉE<br />
(71) Nippon Steel Chemical Co., Ltd., 14-1,<br />
Sotokanda 4-chome, Chiyoda-ku Tokyo 101-<br />
0021, JP<br />
(72) AZUMA, Jun-ichi, Kyoto 606-8502, JP<br />
SAKAMOTO, Tetsuo, Tokyo 101-0021, JP<br />
ONISHI, Kiyotaka, Tokyo 101-0021, JP<br />
(74) Giles, Ashley Simon, et al, Haseltine Lake<br />
LLP Lincoln House, 5th Floor 300 High<br />
Holborn, London WC1V 7JH, GB<br />
C07H 3/02 → (51) C07G 1/00<br />
C07H 21/04 → (51) A61K <strong>31</strong>/713<br />
C07H 21/04 → (51) C12N 9/24<br />
C07H 21/04 → (51) C12Q 1/70<br />
(51) C07J 63/00 (11) 2 213 679 A1<br />
A61K <strong>31</strong>/56 A61P 35/00<br />
(25) Zh (26) En<br />
(21) 08855158.5 (22) 05.11.2008<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MT NL<br />
NO PL PT RO SE SI SK TR<br />
AL BA MK RS<br />
(86) CN 2008/072959 05.11.2008<br />
(87) WO 2009/067891 2009/23 04.06.2009<br />
(30) 16.11.2007 CN 200710170537<br />
(54) • WASSERLÖSLICHE TRITERPENPHENOL-<br />
VERBINDUNGEN MIT ANTITUMOR-WIR-<br />
KUNG UND IHRE HERSTELLUNG<br />
• WATER-SOLUBLE TRITERPENEPHENOL<br />
COMPOUNDS HAVING ANTITUMOR<br />
ACTIVITY AND THE PREPARATION<br />
THEREOF<br />
Europäisches <strong>Patent</strong>blatt<br />
<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />
<strong>Bulletin</strong> européen des brevets<br />
• COMPOSÉS DE TRITERPÈNEPHÉNOL<br />
SOLUBLES DANS L'EAU AYANT UNE<br />
ACTIVITÉ ANTI-TUMORALE ET LEUR<br />
PRÉPARATION<br />
(71) Shanghai Huatuo Medical Science Co., Ltd,<br />
90 Shulan Road Yangpu District, Shanghai<br />
200333, CN<br />
(72) ZENG, Jiafeng, Shanghai 200333, CN<br />
PAN, Junfang, Shanghai 200333, CN<br />
LI, Baoying, Shanghai 200333, CN<br />
ZHU, Qin, Shanghai 200333, CN<br />
FANG, Tong, Shanghai 200333, CN<br />
NI, Huiyan, Shanghai 200333, CN<br />
(74) Gulde Hengelhaupt Ziebig & Schneider,<br />
<strong>Patent</strong>anwälte - Rechtsanwälte Wallstrasse<br />
58/59, 10179 Berlin, DE<br />
(51) C07K 4/12 (11) 2 213 680 A1<br />
A61K 38/03<br />
(25) En (26) En<br />
(21) 10156101.7 (22) 19.07.2007<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />
RO SE SI SK TR<br />
AL BA HR MK RS<br />
(30) 09.08.2006 IT MI20061607<br />
(54) • PEPTIDE MIT PHARMAKOLOGISCHER<br />
AKTIVITÄT ZUR BEHANDLUNG VON<br />
KRANKHEITEN DIE MIT VERÄNDERTER<br />
ZELLMIGRATION ASSOZIIERT SIND, WIE<br />
KREBS<br />
• PEPTIDES HAVING PHARMACOLOGICAL<br />
ACTIVITY FOR TREATING DISORDERS<br />
ASSOCIATED WITH ALTERED CELL<br />
MIGRATION, SUCH AS CANCER<br />
• PEPTIDES AYANT UNE ACTIVITÉ PHAR-<br />
MACOLOGIQUE POUR TRAITER DES<br />
DÉSORDRES ASSOCIÉS À LA MIGRATION<br />
ALTÉRÉE DES CELLULES, TELS QUE LE<br />
CANCER<br />
(71) Carriero, Maria Vincenza, Via Domenico<br />
Fontana 135, 801<strong>31</strong> Napoli, IT<br />
De Rosa, Mario, Via Nicolardi, 188, I-801<strong>31</strong><br />
Napoli, IT<br />
Pavone, Vincenzo, Via Crispi <strong>31</strong>, 80121<br />
Napoli, IT<br />
(72) Carriero, Maria Vincenza, 801<strong>31</strong> Napoli, IT<br />
De Rosa, Mario, I-801<strong>31</strong> Napoli, IT<br />
Pavone, Vincenzo, 80121 Napoli, IT<br />
(74) Minoja, Fabrizio, Bianchetti Bracco Minoja S.<br />
r.l. Via Plinio 63, 20129 Milano, IT<br />
(62) 07786192.0 / 2 049 562<br />
C07K 5/04 → (51) A61K 38/00<br />
C07K 7/06 → (51) A61K 39/07<br />
C07K 14/00 → (51) A61K 38/00<br />
C07K 14/005 → (51) C12N 15/09<br />
C07K 14/035 → (51) A61K 39/245<br />
C07K 14/21 → (51) A61K <strong>31</strong>/203<br />
C07K 14/245 → (51) A61K <strong>31</strong>/203<br />
C07K 14/28 → (51) A61K <strong>31</strong>/203<br />
C07K 14/<strong>31</strong> → (51) A61K 39/07<br />
C07K 14/<strong>31</strong> → (51) C12N 15/09<br />
C07K 14/32 → (51) C12N 15/75<br />
(51) C07K 14/325 (11) 2 213 681 A1<br />
(25) En (26) En<br />
(21) 10075098.3 (22) 20.03.2003<br />
292<br />
Anmeldungen<br />
Applications<br />
Demandes (<strong>31</strong>/<strong>2010</strong>) 04.08.<strong>2010</strong><br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IT LI LU MC NL PT RO SE SI SK<br />
TR<br />
(30) 22.03.2002 US 366276 P<br />
06.11.2002 US 423999 P<br />
(54) • Neue insektizide Proteine von Bazillus<br />
Thuringiensis<br />
• Novel Bacillus thuringiensis insecticidal<br />
proteins<br />
• Nouvelles protéines insecticides à base de<br />
Bacillus thuringiensis<br />
(71) Bayer BioScience N.V., Technologiepark 38,<br />
9052 Gent, BE<br />
(72) Arnaut, Greta, 9910 Knesselare, BE<br />
Boets, Annemie, 9620 Velzeke, BE<br />
Vanneste, Stijn, 8500 Kortrijk, BE<br />
Van Rie, Jeroen, 9900 Eeklo, BE<br />
De Rudder, Karel, 4564 CS Sint Jansteen, NL<br />
(62) 03744850.3 / 1 490 397<br />
C07K 14/505 → (51) C12N 15/62<br />
(51) C07K 14/715 (11) 2 213 682 A1<br />
C07K 16/24 A61K 38/17<br />
A61P 37/02 A61P 35/00<br />
A61P <strong>31</strong>/12 G01N 33/53<br />
G01N 33/574<br />
(25) En (26) En<br />
(21) 09305092.0 (22) 30.01.2009<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MK MT<br />
NL NO PL PT RO SE SI SK TR<br />
AL BA RS<br />
(54) • TSLP fördert Immunevasion und Persistenz<br />
von Viren<br />
• TSLP promotes immune evasion and<br />
persistence of viruses<br />
• TSLP favorisant l'évasion immunitaire et la<br />
persistance de virus<br />
(71) Institut Curie, 26, rue d'Ulm, 75248 Paris<br />
Cedex 05, FR<br />
(72) Soumelis, Vassili, 75013 Paris, FR<br />
Fernandez, Isabel, 75013 Paris, FR<br />
(74) Blot, Philippe Robert Emile, Cabinet Lavoix 2,<br />
place d'Estienne d'Orves, 75441 Paris Cedex<br />
09, FR<br />
(51) C07K 16/00 (11) 2 213 683 A1<br />
C12N 15/12 C12N 5/10<br />
A61K 39/395 C07K 16/28<br />
(25) En (26) En<br />
(21) 0816<strong>31</strong>00.4 (22) 18.07.2005<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />
SE SI SK TR<br />
(27) 18.07.2005 PCT/US2005/025276<br />
(30) 04.08.2004 US 598855 P<br />
19.08.2004 US 602953 P<br />
25.08.2004 US 604339 P<br />
10.09.2004 US 609101 P<br />
23.12.2004 US 638442 P<br />
13.01.2005 US 643718 P<br />
(54) • Varianten der Fc Regionen<br />
• Variant Fc regions<br />
• Régions Fc variantes<br />
(71) Applied Molecular Evolution, Inc., 3520<br />
Dunhill Street, San Diego, CA 92121, US<br />
(72) Allan, Barrett, Encinitas, CA 92121, US<br />
Jiang, Weidong, San Jose, CA 95129, US<br />
Tang, Ying, San Diego, CA 92129, US<br />
Watkins, Jeffry Dean, Encinitas, CA 92024,<br />
US<br />
(74) Ingham, Stephen H., et al, Eli Lilly and<br />
Company Ltd <strong>European</strong> <strong>Patent</strong> Operations<br />
Lilly Research Centre Erl Wood Manor<br />
Sunninghill Road, Windlesham, Surrey,<br />
GU20 6PH, GB
Change language